A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2016; you can also visit the original URL.
The file type is
Long term use of curcumin in two smoldering multiple myeloma patients
Journal of Hematological Malignancies
Smoldering Multiple Myeloma (SMM) is an asymptomatic plasma cell disorder which has an overall risk of progression to multiple myeloma of 10% per year. The cornerstone of managing SMM is a "watch and wait" strategy. Curcumin has been shown to improve disease status in some patients with MGUS and SMM and has been added to the mainstream treatment of myeloma patients. We report here for the first time on long term use of oral curcumin in 2 SMM patients. Patients: Two male Caucasian patients overdoi:10.5430/jhm.v3n1p18 fatcat:tizgllotgrdv5erybrmpa7xo74